12,320 Shares in Grail, Inc. (NASDAQ:GRAL) Purchased by Burren Capital Advisors Ltd

Burren Capital Advisors Ltd acquired a new stake in shares of Grail, Inc. (NASDAQ:GRAL) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 12,320 shares of the company’s stock, valued at approximately $220,000. Grail accounts for 1.1% of Burren Capital Advisors Ltd’s investment portfolio, making the stock its 14th largest holding.

Other institutional investors have also modified their holdings of the company. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors purchased a new stake in shares of Grail in the fourth quarter valued at $244,000. Moloney Securities Asset Management LLC bought a new stake in Grail in the fourth quarter worth about $559,000. Wesbanco Bank Inc. bought a new stake in Grail in the fourth quarter worth about $523,000. Slow Capital Inc. purchased a new position in shares of Grail during the fourth quarter valued at approximately $2,379,000. Finally, abrdn plc bought a new position in shares of Grail during the fourth quarter valued at approximately $3,768,000.

Grail Price Performance

NASDAQ GRAL opened at $32.88 on Friday. The company’s 50-day simple moving average is $30.64 and its two-hundred day simple moving average is $20.81. Grail, Inc. has a one year low of $12.33 and a one year high of $63.99.

Grail (NASDAQ:GRAL) last issued its quarterly earnings data on Thursday, February 20th. The company reported ($1.86) EPS for the quarter, topping analysts’ consensus estimates of ($4.41) by $2.55. The business had revenue of $38.25 million during the quarter, compared to the consensus estimate of $35.33 million. Analysts predict that Grail, Inc. will post -15.15 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on the company. Morgan Stanley began coverage on Grail in a report on Wednesday, November 27th. They set an “equal weight” rating and a $16.00 price objective for the company. Wolfe Research initiated coverage on shares of Grail in a research note on Friday, November 15th. They set a “peer perform” rating for the company.

About Grail

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.